Table 7 Results from bio-assays using WHO cone test
Variable | 12 months | 24 months | 36 months |
|---|---|---|---|
Unguja–PermaNet 2.0 | N = 30 | N = 30 | N = 30 |
Knockdown 60 min | |||
Mean (95% CI) | 89.0% (83.9–94.3) | 97.8% (96.6–99.0) | 96.9% (94.1–99.7) |
Median (IQR) | 92.0% (84.0–98.0) | 100% (96.0–100) | 100% (96.0–100) |
Mortality 24 h | |||
Mean (95% CI) | 92.1% (88.3–95.9) | 86.4% (80.5–92.3) | 71.5% (66.0–76.9) |
Median (IQR) | 93.0% (88.0–100) | 89.0% (82.0–96.0) | 72.0% (64.0–80.0) |
Optimal effectiveness | |||
Estimate (95% CI) | 90.0% (63.5–97.9) | 96.7% (77.7–99.6) | 90.0% (63.4–97.9) |
Minimal effectiveness | |||
Estimate (95% CI) | 100% | 100% | 100% |
Optimal effectiveness | |||
(incl. tunnel) Estimate (95% CI) | – | 100% | 100% |
Minimal effectiveness | |||
(incl. tunnel) Estimate (95% CI) | – | 100% | 100% |
Pemba–Olyset | N = 30 | N = 30 | N = 30 |
|---|---|---|---|
Knockdown 60 min | |||
Mean (95% CI) | 86.7% (82.9–90.4) | 77.9% (72.1–83.7) | 87.4% (83.2–91.6) |
Median (IQR) | 90.0% (80.0–96.0) | 80.0% (66.0–90.0) | 93.0% (78.0–98.0) |
Mortality 24 h | |||
Mean (95% CI) | 76.6% (69.4–83.8) | 55.9% (49.2–62.5) | 47.9% (39.1–56.6) |
Median (IQR) | 77.0% (68.0–88.0) | 52.0% (46.0–70.0) | 44.0% (30.0–68.0) |
Optimal effectiveness | |||
Estimate (95% CI) | 53.0% (32.8–72.8) | 20.0% (9.8–36.6) | 50.0% (30.5–69.5) |
Minimal effectiveness | |||
Estimate (95% CI) | 96.7% (77.7–99.6) | 76.7% (52.3–90.8) | 90.0% (71.3–97.0) |
Optimal effectiveness | |||
(incl. tunnel) Estimate (95% CI) | 96.7% (77.7–99.6) | 80.0% (58.4–91.9) | 100% |
Minimal effectiveness | |||
(incl. tunnel) Estimate (95% CI) | 100% | 96.7% (77.7–99.6) | 100% |